China Meheco Group Co., Ltd. (SHA: 600056)
China
· Delayed Price · Currency is CNY
10.67
-0.11 (-1.02%)
Jan 3, 2025, 3:00 PM CST
China Meheco Group Revenue
China Meheco Group had revenue of 8.30B CNY in the quarter ending September 30, 2024, with 1.60% growth. This brings the company's revenue in the last twelve months to 35.13B, down -13.21% year-over-year. In the year 2023, China Meheco Group had annual revenue of 38.82B with 3.28% growth.
Revenue (ttm)
35.13B
Revenue Growth
-13.21%
P/S Ratio
0.45
Revenue / Employee
4.19M
Employees
8,389
Market Cap
15.96B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 38.82B | 1.23B | 3.28% |
Dec 31, 2022 | 37.59B | 1.36B | 3.75% |
Dec 31, 2021 | 36.23B | -3.08B | -7.83% |
Dec 31, 2020 | 39.31B | 4.03B | 11.41% |
Dec 31, 2019 | 35.28B | 4.28B | 13.80% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
Jiangsu Hengrui Medicine | 26.00B |
WuXi AppTec | 38.50B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Aier Eye Hospital Group | 20.62B |
Shanghai United Imaging Healthcare | 10.93B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Beijing Wantai Biological Pharmacy Enterprise | 2.49B |